Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Saved in:
| Title: | Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib. |
|---|---|
| Authors: | Coombes RC; Imperial College, South Kensington, London, UK., Howell S; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Lord SR; Early Phase Clinical Trials Unit, Department of Oncology, University of Oxford, Oxford, UK., Kenny L; Imperial College, South Kensington, London, UK., Mansi J; Guy's and St Thomas' NHS Foundation Trust, London, UK., Mitri Z; OHSU Knight Cancer Institute, Portland, OR, USA., Palmieri C; University of Liverpool, Liverpool, UK., Chap LI; University of California, Los Angeles, CA, USA., Richards P; Blue Ridge Cancer Center, Salem, VA, USA., Gradishar W; Northwestern University, Chicago, IL, USA., Sardesai S; US Oncology Research, OHC, Cincinnati, OH, USA., Melear J; Baylor University Medical Center, Texas Oncology, Dallas, TX, USA., O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, Dallas, TX, USA., Ward P; US Oncology Research, OHC, Cincinnati, OH, USA., Chalasani P; University of Arizona Cancer Center, Tucson, AZ, USA., Arkenau T; Sarah Cannon Research Institute, London, UK., Baird RD; Cancer Research UK Cambridge Centre, Cambridge, UK., Jeselsohn R; Dana-Farber Cancer Institute, Boston, MA, USA., Ali S; Imperial College, South Kensington, London, UK., Clack G; Carrick Therapeutics, Dublin, Ireland., Bahl A; Carrick Therapeutics, Dublin, Ireland., McIntosh S; Carrick Therapeutics, Dublin, Ireland., Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. matthew.krebs@manchester.ac.uk. |
| Source: | Nature communications [Nat Commun] 2023 Aug 07; Vol. 14 (1), pp. 4741. Date of Electronic Publication: 2023 Aug 07. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-023-40561-x |
